Electrical Equipment & Parts
Build Your Comparison
Side-by-side financial analysisStock Comparison
ELVA vs CAT vs DE vs CBAT vs CNH vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural - Machinery
Agricultural - Machinery
Electrical Equipment & Parts
Agricultural - Machinery
Banks - Diversified
ELVA vs CAT vs DE vs CBAT vs CNH vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||||
|---|---|---|---|---|---|---|
| Industry | Electrical Equipment & Parts | Agricultural - Machinery | Agricultural - Machinery | Electrical Equipment & Parts | Agricultural - Machinery | Banks - Diversified |
| Market Cap | $407M | $458.69B | $159.06B | $61M | $12.98B | $908.57B |
| Revenue (TTM) | $71M | $70.75B | $46.86B | $230M | $18.09B | $280.33B |
| Net Income (TTM) | $5M | $9.42B | $4.78B | $-17M | $386M | $57.05B |
| Gross Margin | 31.1% | 32.5% | 35.4% | 6.4% | 31.4% | 60.0% |
| Operating Margin | 10.2% | 16.6% | 18.4% | -11.1% | 14.6% | 25.9% |
| Forward P/E | 82.5x | 40.0x | 32.6x | — | 25.8x | 14.6x |
| Total Debt | $23M | $43.33B | $63.94B | $30M | $27.03B | $942.38B |
| Cash & Equiv. | $6M | $9.98B | $8.28B | $8.30B | $3.23B | $343.34B |
ELVA vs CAT vs DE vs CBAT vs CNH vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Electrovaya Inc. (ELVA) | 100 | 992.4 | +892.4% |
| Caterpillar Inc. (CAT) | 100 | 779.3 | +679.3% |
| Deere & Company (DE) | 100 | 375.0 | +275.0% |
| CBAK Energy Technol… (CBAT) | 100 | 89.9 | -10.1% |
| CNH Industrial N.V. (CNH) | 100 | 148.8 | +48.8% |
| JPMorgan Chase & Co. (JPM) | 100 | 345.8 | +245.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ELVA vs CAT vs DE vs CBAT vs CNH vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ELVA has the current edge in this matchup, primarily because of its strength in growth exposure.
- Rev growth 42.6%, EPS growth 286.7%, 3Y rev CAGR 59.7%
- 42.6% revenue growth vs DE's -11.6%
- +205.6% vs CBAT's -40.6%
CAT ranks third and is worth considering specifically for long-term compounding.
- 12.5% 10Y total return vs DE's 6.4%
- 10.0% ROA vs CBAT's -0.0%, ROIC 15.9% vs -0.0%
DE is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.54, current ratio 2.31x
- Beta 0.54 vs ELVA's 2.76
CBAT doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.
CNH is the clearest fit if your priority is defensive.
- Beta 1.14, yield 2.5%, current ratio 7.75x
- 2.5% yield, vs CAT's 0.6%, (2 stocks pay no dividend)
JPM is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 15 yrs, beta 0.87, yield 1.8%
- PEG 0.83 vs ELVA's 7.04
- Lower P/E (14.6x vs 25.8x)
- 20.4% margin vs CBAT's -7.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 42.6% revenue growth vs DE's -11.6% | |
| Value | Lower P/E (14.6x vs 25.8x) | |
| Quality / Margins | 20.4% margin vs CBAT's -7.4% | |
| Stability / Safety | Beta 0.54 vs ELVA's 2.76 | |
| Dividends | 2.5% yield, vs CAT's 0.6%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +205.6% vs CBAT's -40.6% | |
| Efficiency (ROA) | 10.0% ROA vs CBAT's -0.0%, ROIC 15.9% vs -0.0% |
ELVA vs CAT vs DE vs CBAT vs CNH vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ELVA vs CAT vs DE vs CBAT vs CNH vs JPM — Financial Metrics
Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CAT leads in 2 of 6 categories
JPM leads 1 • CBAT leads 1 • ELVA leads 0 • DE leads 0 • CNH leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 3962.8x ELVA's $71M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to CBAT's -7.4%. On growth, CBAT holds the edge at +99.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $71M | $70.8B | $46.9B | $230M | $18.1B | $280.3B |
| EBITDAEarnings before interest/tax | $9M | $14.0B | $10.3B | -$14M | $3.3B | $81.4B |
| Net IncomeAfter-tax profit | $5M | $9.4B | $4.8B | -$17M | $386M | $57.0B |
| Free Cash FlowCash after capex | -$34M | $11.4B | $3.8B | $37M | $1.8B | $100.9B |
| Gross MarginGross profit ÷ Revenue | +31.1% | +32.5% | +35.4% | +6.4% | +31.4% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +10.2% | +16.6% | +18.4% | -11.1% | +14.6% | +25.9% |
| Net MarginNet income ÷ Revenue | +7.1% | +13.3% | +10.2% | -7.4% | +2.1% | +20.4% |
| FCF MarginFCF ÷ Revenue | -48.1% | +16.2% | +8.0% | +16.0% | +10.2% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +18.5% | +22.2% | +6.7% | +99.3% | -0.1% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -5.8% | +30.2% | -1.4% | -4.7% | -94.4% | +16.0% |
Valuation Metrics
CBAT leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 16.2x trailing earnings, JPM trades at a 87% valuation discount to ELVA's 127.7x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.92x vs ELVA's 10.90x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Market CapShares × price | $407M | $458.7B | $159.1B | $61M | $13.0B | $908.6B |
| Enterprise ValueMkt cap + debt − cash | $423M | $492.0B | $214.7B | -$8.2B | $36.8B | $1.51T |
| Trailing P/EPrice ÷ TTM EPS | 127.70x | 52.35x | 31.85x | -6.83x | 25.51x | 16.22x |
| Forward P/EPrice ÷ next-FY EPS est. | 82.50x | 39.97x | 32.60x | — | 25.81x | 14.60x |
| PEG RatioP/E ÷ EPS growth rate | 10.90x | 1.86x | 1.95x | — | — | 0.92x |
| EV / EBITDAEnterprise value multiple | 59.92x | 36.52x | 20.17x | — | 10.76x | 18.52x |
| Price / SalesMarket cap ÷ Revenue | 6.41x | 6.79x | 3.56x | 0.31x | 0.72x | 3.25x |
| Price / BookPrice ÷ Book value/share | 13.85x | 21.69x | 6.16x | 0.00x | 1.67x | 2.51x |
| Price / FCFMarket cap ÷ FCF | — | 44.65x | 49.23x | 0.02x | 6.50x | 9.01x |
Profitability & Efficiency
CAT leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
CAT delivers a 47.5% return on equity — every $100 of shareholder capital generates $48 in annual profit, vs $-0 for CBAT. CBAT carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to CNH's 3.45x. On the Piotroski fundamental quality scale (0–9), DE scores 6/9 vs CBAT's 4/9, reflecting solid financial health.
| Metric | ||||||
|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +11.3% | +47.5% | +18.2% | -0.1% | +4.9% | +15.9% |
| ROA (TTM)Return on assets | +6.2% | +10.0% | +4.5% | -0.0% | +0.9% | +1.3% |
| ROICReturn on invested capital | +10.9% | +15.9% | +7.8% | -0.0% | +6.6% | +4.5% |
| ROCEReturn on capital employed | +17.1% | +19.1% | +11.7% | -0.0% | +8.3% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 6 | 4 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.72x | 2.03x | 2.46x | 0.00x | 3.45x | 2.60x |
| Net DebtTotal debt minus cash | $16M | $33.4B | $55.7B | -$8.3B | $23.8B | $599.0B |
| Cash & Equiv.Liquid assets | $6M | $10.0B | $8.3B | $8.3B | $3.2B | $343.3B |
| Total DebtShort + long-term debt | $23M | $43.3B | $63.9B | $30M | $27.0B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 2.23x | 9.22x | 3.07x | -43.42x | 1.76x | 0.74x |
Total Returns (Dividends Reinvested)
CAT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CAT five years ago would be worth $48,451 today (with dividends reinvested), compared to $1,384 for CBAT. Over the past 12 months, ELVA leads with a +205.6% total return vs CBAT's -40.6%. The 3-year compound annual growth rate (CAGR) favors CAT at 60.8% vs CBAT's -20.3% — a key indicator of consistent wealth creation.
| Metric | ||||||
|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +31.6% | +65.2% | +26.6% | -20.5% | +12.9% | +0.8% |
| 1-Year ReturnPast 12 months | +205.6% | +175.7% | +13.5% | -40.6% | -17.6% | +20.9% |
| 3-Year ReturnCumulative with dividends | +179.4% | +315.8% | +48.9% | -49.4% | -21.1% | +138.8% |
| 5-Year ReturnCumulative with dividends | +82.8% | +384.5% | +87.3% | -86.2% | -26.1% | +135.5% |
| 10-Year ReturnCumulative with dividends | -29.6% | +1247.4% | +636.2% | -74.4% | +68.5% | +481.2% |
| CAGR (3Y)Annualised 3-year return | +40.8% | +60.8% | +14.2% | -20.3% | -7.6% | +33.7% |
Risk & Volatility
Evenly matched — CAT and DE each lead in 1 of 2 comparable metrics.
Risk & Volatility
DE is the less volatile stock with a 0.54 beta — it tends to amplify market swings less than ELVA's 2.76 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CAT currently trades 99.1% from its 52-week high vs CBAT's 55.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.76x | 1.64x | 0.54x | 1.12x | 1.14x | 0.87x |
| 52-Week HighHighest price in past year | $12.75 | $994.49 | $674.19 | $1.24 | $14.27 | $338.09 |
| 52-Week LowLowest price in past year | $3.11 | $356.96 | $433.00 | $0.66 | $9.00 | $269.72 |
| % of 52W HighCurrent price vs 52-week peak | +81.7% | +99.1% | +87.4% | +55.1% | +73.3% | +96.2% |
| RSI (14)Momentum oscillator 0–100 | 47.2 | 61.4 | 58.1 | 31.7 | 45.5 | 72.1 |
| Avg Volume (50D)Average daily shares traded | 424K | 2.5M | 1.1M | 105K | 12.5M | 7.4M |
Analyst Outlook
Evenly matched — CAT and CNH each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ELVA as "Buy", CAT as "Buy", DE as "Hold", CNH as "Buy", JPM as "Buy". Consensus price targets imply 67.9% upside for ELVA (target: $18) vs -10.5% for CAT (target: $882). For income investors, CNH offers the higher dividend yield at 2.54% vs CAT's 0.59%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | — | Buy | Buy |
| Price TargetConsensus 12-month target | $17.50 | $882.20 | $690.00 | — | $13.09 | $339.75 |
| # AnalystsCovering analysts | 3 | 53 | 46 | — | 14 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | +0.6% | +1.1% | — | +2.5% | +1.8% |
| Dividend StreakConsecutive years of raises | — | 32 | 5 | 1 | 0 | 15 |
| Dividend / ShareAnnual DPS | — | $5.86 | $6.33 | — | $0.27 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.1% | +0.7% | +2.5% | 0.0% | +3.8% |
CAT leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). JPM leads in 1 (Income & Cash Flow). 2 tied.
ELVA vs CAT vs DE vs CBAT vs CNH vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ELVA or CAT or DE or CBAT or CNH or JPM a better buy right now?
For growth investors, Electrovaya Inc.
(ELVA) is the stronger pick with 42. 6% revenue growth year-over-year, versus -11. 6% for Deere & Company (DE). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 2x trailing P/E (14. 6x forward), making it the more compelling value choice. Analysts rate Electrovaya Inc. (ELVA) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ELVA or CAT or DE or CBAT or CNH or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 2x versus Electrovaya Inc. at 127. 7x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 83x versus Electrovaya Inc. 's 7. 04x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ELVA or CAT or DE or CBAT or CNH or JPM?
Over the past 5 years, Caterpillar Inc.
(CAT) delivered a total return of +384. 5%, compared to -86. 2% for CBAK Energy Technology, Inc. (CBAT). Over 10 years, the gap is even starker: CAT returned +1247% versus CBAT's -74. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ELVA or CAT or DE or CBAT or CNH or JPM?
By beta (market sensitivity over 5 years), Deere & Company (DE) is the lower-risk stock at 0.
54β versus Electrovaya Inc. 's 2. 76β — meaning ELVA is approximately 408% more volatile than DE relative to the S&P 500. On balance sheet safety, CBAK Energy Technology, Inc. (CBAT) carries a lower debt/equity ratio of 0% versus 3% for CNH Industrial N. V. — giving it more financial flexibility in a downturn.
05Which is growing faster — ELVA or CAT or DE or CBAT or CNH or JPM?
By revenue growth (latest reported year), Electrovaya Inc.
(ELVA) is pulling ahead at 42. 6% versus -11. 6% for Deere & Company (DE). On earnings-per-share growth, the picture is similar: Electrovaya Inc. grew EPS 286. 7% year-over-year, compared to -176. 9% for CBAK Energy Technology, Inc.. Over a 3-year CAGR, ELVA leads at 59. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ELVA or CAT or DE or CBAT or CNH or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus -4. 8% for CBAK Energy Technology, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -9. 6% for CBAT. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ELVA or CAT or DE or CBAT or CNH or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 83x versus Electrovaya Inc. 's 7. 04x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 6x forward P/E versus 82. 5x for Electrovaya Inc. — 67. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ELVA: 67. 9% to $17. 50.
08Which pays a better dividend — ELVA or CAT or DE or CBAT or CNH or JPM?
In this comparison, CNH (2.
5% yield), JPM (1. 8% yield), DE (1. 1% yield), CAT (0. 6% yield) pay a dividend. ELVA, CBAT do not pay a meaningful dividend and should not be held primarily for income.
09Is ELVA or CAT or DE or CBAT or CNH or JPM better for a retirement portfolio?
For long-horizon retirement investors, Deere & Company (DE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
54), 1. 1% yield, +636. 2% 10Y return). Electrovaya Inc. (ELVA) carries a higher beta of 2. 76 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DE: +636. 2%, ELVA: -29. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ELVA and CAT and DE and CBAT and CNH and JPM?
These companies operate in different sectors (ELVA (Industrials) and CAT (Industrials) and DE (Industrials) and CBAT (Industrials) and CNH (Industrials) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ELVA is a small-cap high-growth stock; CAT is a large-cap quality compounder stock; DE is a mid-cap quality compounder stock; CBAT is a small-cap quality compounder stock; CNH is a mid-cap quality compounder stock; JPM is a large-cap deep-value stock. CAT, DE, CNH, JPM pay a dividend while ELVA, CBAT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.